Jazz Pharmaceuticals (JAZZ) stock has confirmed a bullish breakout by closing above its May high of $243.32, following a long-term base breakout and a bullish flag pattern. This technical setup suggests a continuation of the upward trend, supported by key moving averages like the 50-day and 20-day averages. If momentum holds, the stock is likely to see further upside, indicating a strong potential for sustained gains in the near term.
Grabar Law Office is investigating claims against officers and directors of First Solar, Hub Group, Navan, and ZoomInfo for alleged breaches of fiduciary duties and securities fraud. The investigations focus on misleading statements and omissions rel...
Osprey Acquisition Corp. III completed its initial public offering (IPO), raising $300.15 million by selling 30,015,000 units at $10 each, including an over-allotment option. The units, trading on Nasdaq under ticker OSPRU, consist of Class A shares ...
Galloper Gold Corp. has signed a multi-year strategic partnership with Tripp Marine to handle heavy equipment barging for its Glover Island exploration project in Newfoundland. The partnership, effective July 1, 2026, aims to provide cost-effective a...
Ero Copper Corp. announced it will publish its second quarter 2026 operating and financial results on August 5, 2026, after market close. The company will hold a conference call on August 6 to discuss the results, providing investors an opportunity t...
The June employment report revealed a significant slowdown in job growth, with only 57,000 new payrolls added, well below expectations. The labor force participation rate dropped to 61.5%, causing the unemployment rate to fall to 4.2%. Wage growth re...
